Fidelity Investments
RDHL

Fidelity Investments’s Redhill Biopharma RDHL Stock Holding History

Fidelity Investments’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-93
Closed -$423K – 4069
2020
Q1 		$423K Hold
93
– – ﹤0.01% 2460
2019
Q4 		$566K Hold
93
– – ﹤0.01% 2483
2019
Q3 		$657K Hold
93
– – ﹤0.01% 2482
2019
Q2 		$606K Hold
93
– – ﹤0.01% 2510
2019
Q1 		$775K Sell
93
-107
-54% -$846K ﹤0.01% 2450
2018
Q4 		$1.11M Buy
+200
New +$1.53M ﹤0.01% 2387

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Fidelity Investments's RDHL Position: Q2 2020 in Review

Fidelity Investments sold out of Redhill Biopharma (RDHL) in Q2 2020, closing a stake of 93 shares — an estimated $423K sold.

Fidelity Investments first reported a position in RDHL in Q4 2018 and held it in 6 quarters. The position peaked at $1.11M in Q4 2018. 41 funds tracked by Wall St. Rank hold RDHL as of Q2 2020.

  • Fidelity Investments reported no remaining Redhill Biopharma position as of Q2 2020 after selling out during the quarter.
  • Fidelity Investments sold 93 Redhill Biopharma shares in Q2 2020, an estimated $423K.
  • Fidelity Investments first reported a position in Redhill Biopharma in Q4 2018 and held it in 6 quarters.
  • Fidelity Investments's Redhill Biopharma position peaked at $1.11M in Q4 2018.
  • 41 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2020.

Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.